Is Ashwagandha Banned in Europe? France, Denmark & the 2026 Outlook
Short answer: ashwagandha is not banned across the whole European Union, but it is already prohibited in food supplements in Denmark, formally restricted through safety warnings in France, and under active review in several other member states. For an Indian brand, that patchwork is exactly where market-entry money is won or lost.
Why one Indian herb has become an EU flashpoint
Ashwagandha is one of the most exported ingredients in the Indian wellness and ayurveda sector. It is also one of the most scrutinised botanicals in Europe right now. The concern in the EU is not the herb's Indian heritage — it is safety data. European authorities have received reports of adverse effects (particularly relating to the liver, thyroid and hormones) and, in the absence of a full EU safety dossier, several regulators have chosen to act at national level.
This matters because the EU regulates food supplements market-by-market for botanicals. There is no consolidated EU list of permitted plants, which means an ingredient can be freely sold in one member state and prohibited in the one next door.
Where ashwagandha stands, country by country (2026)
Denmark — effectively banned
Denmark's authorities have concluded that ashwagandha should not be used in food supplements, making it the clearest prohibition in the EU. Products containing it are not permitted on the Danish market.
France — restricted and warned
France's food safety agency, ANSES, issued an opinion in 2024 advising against ashwagandha for pregnant and breastfeeding women, under-18s, and people with thyroid, liver, heart or hormonal conditions. France has moved toward restricting the ingredient, and several sources report it being pulled from general food-supplement sale.
Sweden, Finland and others — under review
Regulators in Sweden and Finland have signalled that they may follow Denmark. The direction of travel across northern and western Europe is toward tighter control, not looser.
Much of the EU — currently permitted, conditionally
In many member states ashwagandha can still be sold, often with dosage limits, warning labels or specific extract conditions. "Permitted" is not the same as "unconditional" — the responsibility to prove the product is safe sits with the company placing it on the market.
What this means for an Indian brand
If your hero product contains ashwagandha, you cannot treat "Europe" as one launch. A compliant plan looks like this:
- Screen the ingredient before you ship. Confirm the status of ashwagandha — and its specific extract, dose and withanolide content — in each target country.
- Sequence your markets. Launch first where the ingredient is clearly permitted, not where it is banned or contested.
- Get the label right. Warnings, dosage and target-group restrictions differ by country and are a common reason for delisting.
- Have a reformulation plan. For restricted markets, a compliant alternative formulation keeps the brand selling instead of frozen.
Not sure if your formulation can legally sell in the EU?
Meridian screens every ingredient, dose and claim against each target market before a euro moves — so budget is never burned on stock that can be seized at the border.
Start an ingredient compliance screen — €199 →Frequently asked questions
Is ashwagandha legal in the European Union?
There is no single EU-wide answer. Ashwagandha is banned in food supplements in Denmark and restricted in France, while it remains permitted (often with conditions) in a number of other member states. Because the EU regulates botanicals country-by-country, its legal status depends on exactly where you sell.
Is ashwagandha banned in France?
France's ANSES has issued a formal warning against ashwagandha for vulnerable groups and has moved to restrict it, with reports of it being removed from general food-supplement sale. Brands should treat France as a restricted market and verify the current position before selling.
Can I sell the same ashwagandha supplement across all of Europe?
No. Selling one formulation EU-wide without checking each country is high-risk, because the ingredient is prohibited in some markets and conditional in others. Products should be screened and markets sequenced before launch.
What should Indian ayurveda brands do about ashwagandha?
Screen the exact extract and dose per market, launch first where it is clearly permitted, get country-specific labelling right, and prepare a compliant alternative formulation for restricted markets.
Meridian Advisory is the trading name of Herbs Fusion SRL, a company established in the European Union (Romania).